Skip to content

Clinical trials

Phase 2 Recurrence trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 2 Country / region: Netherlands Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20122
20132
20141
20152
20161
20171
20183
20191
20202
20211
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated4
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Celgene2
AbbVie1
Amsterdam UMC, location VUmc1
Children's Oncology Group1
Chroma Therapeutics1
Clinica Universidad de Navarra, Universidad de Navarra1
Clovis Oncology, Inc.1
CytomX Therapeutics1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence23
Neoplasms6
Lymphoma, Large B-Cell, Diffuse4
Leukemia3
Leukemia, Myeloid, Acute3
Multiple Myeloma3
Burkitt Lymphoma2
Carcinoma, Non-Small-Cell Lung2
Leukemia, Hairy Cell2
Lymphoma2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.